Discover

PPBT
Purple Biotech Ltd
1.75
2 x 1.66
1 x 5.21
bid
ask
+
0.05
3.24%
2 @ 04:00 PM
1.74 -0.01 (0.57%)
Ytd-73.40%
1y-92.63%
1.71
day range
1.79
1.42
52 week range
29.00
Open1.73Prev Close1.70Low1.71High1.79Mkt Cap1.63M
Vol40.67KAvg Vol306.68KEPS3226.00P/E0.00Forward P/E-1.69
Beta0.38Short Ratio0.43Inst. Own9.33%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg3.11200-d Avg5.371yr Est33.00
Income Statement
Operating Expenses2.25M
Research and Development Expense1.23M
Selling, General and Administrative Expense1.02M
Operating Income-2.25M
Interest Expense31.00K
Net Income86.00K
Net Income Common Stock86.00K
Net Income Common Stock (USD)86.00K
Consolidated Income-89.00K
Net Income to Non-Controlling Interests6.00K
Earning Before Interest & Taxes (EBIT)117.00K
Earning Before Interest & Taxes (USD)117.00K
Weighted Average Shares1.86B
Balance Sheet
Cash and Equivalents5.57M
Cash and Equivalents (USD)5.57M
Investments859.00K
Investments Current859.00K
Current Assets6.78M
Property, Plant & Equipment Net278.00K
Total Assets14.42M
Debt Current184.00K
Total Debt184.00K
Current Liabilities4.59M
Total Liabilities4.75M
Accumulated Retained Earnings (Deficit)-171.17M
Shareholders Equity9.72M
Shareholders Equity (USD)9.72M
Assets Non-Current7.64M
Total Debt (USD)184.00K
Goodwill and Intangible Assets7.36M
Liabilities Non-Current160.00K
Trade and Non-Trade Payables2.51M
Cash Flow
Depreciation, Amortization & Accretion65.00K
Net Cash Flow from Financing-64.00K
Net Cash Flow / Change in Cash & Cash Equivalents-3.14M
Issuance (Repayment) of Debt Securities -59.00K
Net Cash Flow from Investing45.00K
Net Cash Flow - Investment Acquisitions and Disposals2.00K
Net Cash Flow from Operations-3.12M
Share Based Compensation93.00K